Biochemical Response in Asian Primary Biliary Cholangitis: A Strong Signal, but Not the Whole Story
- 22 August 2026
- journal article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (5)
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With Metabolic‐Dysfunction Associated Steatotic Liver DiseaseLiver International, 2026
- Overall Survival and Treatment Outcomes in Patients With Primary Biliary Cholangitis: A 10-Year Single-Center Retrospective Cohort StudyJournal of Clinical and Experimental Hepatology, 2026
- Steatotic liver disease in autoimmune liver disease: Prevalence and clinical impact in a Southeast Asian cohortCanadian Liver Journal, 2026
- Recurrence of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis after Liver TransplantationClinics in Liver Disease, 2026
- Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitisJournal of Hepatology, 2025
- Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver DiseasesLiver International, 2025
- Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-AnalysisClinical Gastroenterology and Hepatology, 2025
- Pharmacologic Treatment of Portal HypertensionClinics in Liver Disease, 2024
- Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patientsHepatology, 2024
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patientsClinical and Molecular Hepatology, 2023